announced today the closing of its previously announced underwritten public offering of 1,600,000 shares of its Class A common stock at a price to the public of $5.00 per share. Net proceeds to ...

Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic ...

Company announces the launch of an underwritten public offering in the United States of up to 8,500,000 ordinary ...

Li-Cycle (NYSE:LICY) Tuesday said that it has commenced an underwritten public offering in the United States to offer and sell units consisting of common shares and warrants to purchase common shares.

Nuvectis Pharma (NVCT) announced the pricing of its previously announced underwritten public offering of 2,700,000 shares of its common stock at a price of $5.00 per share, with expected gross ...

Arcus Biosciences (RCUS) announced the pricing of an underwritten offering of 13,636,364 shares of its common stock at an offering price of ...

Nuvectis Pharma, Inc. has announced the initiation of an underwritten public offering of its common stock, with all shares being offered by the company itself. The offering includes an option for ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced ...